ASR Vermogensbeheer’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Sell
13,667
-102,665
-88% -$8.24M 0.01% 403
2026
Q1
$9.74M Buy
116,332
+49,974
+75% +$3.76M 0.11% 170
2025
Q4
$4.45M Buy
+66,358
New +$4.29M 0.05% 267

Other funds holding CTVA

ASR Vermogensbeheer's CTVA Position: Q2 2026 in Review

ASR Vermogensbeheer reduced its Corteva (CTVA) stake by 88% in Q2 2026, selling an estimated $8.24M and leaving 13,667 shares worth $1.16M. The position accounts for 0.01% of the portfolio, ranked #403.

ASR Vermogensbeheer first reported a position in CTVA in Q4 2025 and has held it in 3 quarters since. The position peaked at $9.74M in Q1 2026. 1,487 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • ASR Vermogensbeheer held 13,667 shares of Corteva worth $1.16M as of Q2 2026.
  • ASR Vermogensbeheer sold 102,665 Corteva shares in Q2 2026, an estimated $8.24M.
  • Corteva made up 0.01% of ASR Vermogensbeheer's portfolio in Q2 2026, its #403 holding.
  • ASR Vermogensbeheer first reported a position in Corteva in Q4 2025 and has held it in 3 quarters since.
  • ASR Vermogensbeheer's Corteva position peaked at $9.74M in Q1 2026.
  • 1,487 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.